CDC25 dual-specificity phosphatases are essential key regulators of eukaryotic cell cycle progression and the CDC25A and B isoforms are over-expressed in different tumors and related cancer cell lines. CDC25s are now considered to be interesting targets in the search for novel anticancer agents. We describe new compounds derived from vitamin K-3 that inhibit CDC25B activity with IC50 values in the low micromolar range. These naphthoquinone derivatives also display antiproliferative activity on HeLa cells as expected for CDC25 inhibitors and inhibit cell growth in a clonogenic assay at submicromolar concentrations. They increase inhibitory tyrosine 15 phosphorylation of CDK and induce the cleavage of PARP, a hallmark of apoptosis. (c) 2005 Elsevier Ltd. All rights reserved.
BOROVKOV, V. V.;FILIPPOVICH, E. I.;EVSTIGNEEVA, R. P., XIMIYA GETEROTSIKL. SOED.,(1988) N 5, 608-616
作者:BOROVKOV, V. V.、FILIPPOVICH, E. I.、EVSTIGNEEVA, R. P.
DOI:——
日期:——
Synthesis and spectral properties of porphyrinquinone derivatives based on deuteroporphyrin IX
作者:V. V. Borovkov、E. I. Filippovich、R. P. Evstigneeva